refer to the BNF and product SmPC for eligibility, dosing, and monitoring requirements
Another, more complex reason, is poor absorption of protein , which can be caused by digestive problems or even alcohol consumption
Lets look closer at these comparisons
In placebo-controlled trials, cholelithiasis was reported in 1.5% and 0.4% of patients treated with Ozempic injection 0.5 mg and 1 mg, respectively, and not reported in placebo-treated patients
In three nested casecontrol studies from England and Wales, involving 440,089 patients with T2DM and without ASCVD treated with non-insulin glucose-lowering medication, combined SGLT2i and GLP-1RA therapy used for primary prevention was associated with 30% lower odds of MACE (defined as myocardial infarction/acute coronary syndrome, stroke/transient ischemic attack, and/or cardiovascular death) compared with other combination regimens (OR, 0.70
The pattern is consistent: when someone reports 'the shots stopped working,' the issue isn't tolerance or dosage